In the past seven years, the drugmaker has received tax breaks worth nearly $40 million in exchange for investing more than $500 million at its Indianapolis properties.
The Indianapolis-based grant maker intends about 25% of the money to help organizations and initiatives in Indiana over three years. Half a million dollars already has been committed to the Central Indiana Racial Equity Fund.
It could be months, or longer, before downtown bustles again with the office workers who help restaurants and other retailers thrive. And the wait might be a death knell for some of those retailers.
Organizers on Tuesday announced the formal launch of a business and community task force that will try to address issues facing downtown Indianapolis stemming from the pandemic and social unrest.
Attorney Angela Freeman, who has spent six years on the board of Women & Hi Tech, recommends using diverse committees—rather than leaving the job to one individual—for hiring and then assigning new employees, especially minority hires, to mentors who are invested in their success.
During her six years on the board of Women & Hi Tech—the last year as its president—Angela Freeman has focused as much on up-and-coming young women and schoolgirls as on supporting the not-for-profit’s members.
West Lafayette-based Bioanalytical Systems’ latest executive departure comes amid recent signs of stability, turnaround and growth for a company that just three years ago was on the verge of sinking.
The judges commended IBJ’s “expansive content that reaches into the corners of transportation, technology, sports, health, higher education, civic affairs, state government and more.”
More than 2,300 people have complained by email to the Indiana Utility Consumer Counselor, which is on track to become the largest number of complaints for any single case in at least a decade.
The Hoosier state has 17,093 industry jobs spread out among 69 companies, from Indianapolis-based drugmaker Eli Lilly and Co. to startups scattered around the state, but mostly in clusters near research universities.
The Indianapolis-based drugmaker said it is launching a global trial for the anti-inflammatory drug baricitinib, which it launched two years ago to treat moderately to severely active rheumatoid arthritis.
The Lilly Foundation’s financial commitment over five years is aimed at finding solutions to racial inequity and social injustice primarily in Indianapolis, its surrounding counties and nationally.
So far, the program has enrolled 275 people with diabetes. Health workers in the neighborhoods have completed more than 2,300 check-ins with them—helping them set up doctors’ visits, coaching them on how to shop for food, and helping them with dozens of related problems, from transportation needs to medical insurance.
We must listen carefully to our brothers and sisters of color, and we must change the circumstances that cause a disparate impact on minorities and the poor.
